Steven Avruch
Direktor/Vorstandsmitglied bei Boston Center for the Arts
Vermögen: 32 593 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Steven Avruch
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
103
| Public Company | Pharmaceuticals: Major | 103 |
| Extinct | Biotechnology | 35 | |
Boston Center for the Arts
5
| Non-Profit Organization | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Steven Avruch
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tectonic Therapeutic, Inc., Tectonic Operating Co., Inc. is a company that is transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is based in Watertown, MA. With its proprietary Geode™ platform, Tectonic aims to unlock the therapeutic utility of some of the most difficult receptors in the class. The company was founded by Andrew Kruse and Timothy A. Springer. Alise S. Reicin has been the CEO of the company since 2020. Tectonic Operating Co. was acquired by AVROBIO, Inc. on June 20, 2024 for $7.56 million. | Miscellaneous Commercial Services | Founder Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer Comptroller/Controller/Auditor | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Founder | |
| BIOVERATIV INC | Biotechnology | Chief Executive Officer General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Toronto | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Massachusetts | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member General Counsel Compliance Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer General Counsel Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President President | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Corporate Officer/Principal Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman Chief Operating Officer | |
| Georgetown University | College/University | Director/Board Member Doctorate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | President Sales & Marketing | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Kanada | 4 |
| Irland | 2 |
| Cayman Islands | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 434 |
| Corporate Officer/Principal | 208 |
| Independent Dir/Board Member | 119 |
| Undergraduate Degree | 76 |
| Chief Executive Officer | 70 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Terry McGuire | 54 |
| Annalisa Jenkins | 51 |
| Bruce Booth | 40 |
| Ian Clark | 35 |
| George Scangos | 33 |
| William Young | 32 |
| Steven Holtzman | 28 |
| Douglas Williams | 25 |
| Timothy Springer | 19 |
| Joanne Viney | 18 |
| Stefan Vitorovic | 17 |
| Glenn Pierce | 17 |
| Adriana Karaboutis | 16 |
| Geoff MacKay | 15 |
| Spyridon Artavanis-Tsakonas | 15 |
- Börse
- Insiders
- Steven Avruch
- Unternehmensverbindungen
